Loading...
XNYS
STVN
Market cap6.03bUSD
Dec 05, Last price  
22.11USD
1D
-3.53%
1Q
-8.45%
IPO
13.15%
Name

Stevanato Group SpA

Chart & Performance

D1W1MN
XNYS:STVN chart
P/E
44.00
P/S
4.69
EPS
0.43
Div Yield, %
0.26%
Shrs. gr., 5y
0.61%
Rev. gr., 5y
15.53%
Revenues
1.10b
+1.72%
536,539,000662,037,000843,900,000983,700,0001,085,354,0001,104,036,000
Net income
118m
-19.13%
39,201,00078,513,000134,321,000142,849,000145,631,000117,778,000
CFO
156m
+48.06%
42,572,000155,656,000133,300,000103,300,000105,210,000155,776,000
Dividend
Jun 04, 20240.058 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
IPO date
Jul 16, 2021
Employees
5,260
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT